Like much of the world, the US Food and Drug Administration is beginning to let staff return to the office, but may be having trouble maximizing its potential benefits, such as interacting with colleagues face-to-face.
John Scott, director of the Division of Biostatistics in the Center for Biologics Evaluation and Research’s Office of Biostatistics and...








